Full-Time

Clinical Research Nurse I

Updated on 5/8/2025

Icon

Icon

10,001+ employees

Consulting and development services for pharmaceuticals

No salary listed

Junior, Mid

Company Does Not Provide H1B Sponsorship

Lenexa, KS, USA

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Biology & Biotech
Required Skills
Google Cloud Platform
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Icon referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Bachelor's degree in Nursing (BSN) from an accredited institution, with current licensure as a Registered Nurse (RN) in the applicable jurisdiction.
  • Minimum of 1-2 years of clinical nursing experience, preferably in a research or academic healthcare setting, with exposure to clinical trial operations and Good Clinical Practice (GCP) guidelines.
  • Strong clinical assessment and critical thinking skills, with the ability to recognize and respond to changes in patient status and communicate effectively with healthcare professionals and study investigators.
  • Knowledge of regulatory requirements governing clinical research, including the International Council for Harmonization (ICH) guidelines and local regulatory requirements, with a commitment to upholding ethical standards and patient confidentiality.
  • Proficiency in electronic medical record (EMR) systems, clinical documentation, and data entry, with a high level of attention to detail and accuracy in recording patient information and study data.
  • Excellent interpersonal and organizational skills, with the ability to work independently and collaboratively in a fast-paced, multidisciplinary environment, while prioritizing competing demands and meeting project deadlines.
Responsibilities
  • Assisting in the planning, implementation, and coordination of clinical research activities in accordance with study protocols, regulatory guidelines, and standard operating procedures (SOPs).
  • Conducting patient assessments, administering study treatments, and performing clinical procedures as required by the research protocol, while ensuring patient safety and compliance with ethical standards.
  • Collecting, recording, and maintaining accurate and complete data documentation, including medical histories, vital signs, adverse events, and laboratory results, in electronic case report forms (eCRFs) and study databases.
  • Collaborating with multidisciplinary teams, including investigators, study coordinators, and regulatory staff, to ensure efficient study conduct, participant recruitment, and retention throughout the duration of the trial.
  • Providing education and counseling to study participants and their families regarding study procedures, treatment regimens, and informed consent, while addressing any questions or concerns that may arise during the course of the study.
Desired Qualifications
  • Experience in a research or academic healthcare setting is preferred.

Icon provides consulting, development, and commercialization services to help clients accelerate the creation of drugs and medical devices. Their services are designed to improve the quality of life by ensuring that these products reach the market efficiently. Icon operates a global network of offices in 53 countries, allowing them to offer a wide range of expertise across various therapeutic areas. Their focus is on reducing the time and cost associated with bringing products to market while maintaining high quality standards. This commitment to quality and efficiency sets Icon apart from its competitors, as they prioritize the specific needs of their clients in the healthcare industry.

Company Size

10,001+

Company Stage

IPO

Headquarters

Ireland

Founded

1990

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with Mural Health enhances trial participant management and engagement.
  • Increased AI use in biomarker detection boosts ICON's neurodegenerative research capabilities.
  • Barry Balfe's appointment as COO strengthens ICON's operational excellence and growth potential.

What critics are saying

  • Securities fraud lawsuit poses financial and reputational risks for ICON.
  • Complexity in multi-indication trials may lead to inefficiencies in clinical development.
  • Underutilization of biomarkers in trials could hinder ICON's research efficiency.

What makes Icon unique

  • ICON's global network spans 53 countries, offering comprehensive clinical research services.
  • Focus on reducing time to market, cost, and increasing quality sets ICON apart.
  • ICON's expertise in multi-indication studies enhances its competitive edge in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

401(k) Retirement Plan

Mental Health Support

Life Insurance

Flexible Work Hours

Company News

BioSpace
May 7th, 2025
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

Alongside the whitepaper, ICON has launched their new Centre for Obesity that delivers expertise and market intelligence with a ready-to-deploy infrastructure of 100 sites and an in-development database of 10,000 pre-screened patients across the breadth of comorbidities related to obesity.

PharmiWeb
May 7th, 2025
Global Icon Survey Shows Need For More Efficient Obesity Clinical Trial Design To Realise Full Potential Of Next-Gen Multi-Indication Therapies

Dublin, Ireland – 7 May – ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic RD for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. As researchers uncover the potential of particular drug classes across interconnected diseases, the commercial opportunities have increased the appetite for additional research that targets multiple indications. The findings indicate that most sponsors (83% of respondents) are pursuing multi-indication approaches in their obesity-related research. However, the survey results also suggest that sponsors may underestimate the complexity of these strategies - particularly when selecting inclusion criteria and endpoints - which can lead to inefficiencies in the clinical development process

Broad Street Hero
Apr 3rd, 2025
An old friend joins the Broadstreet team

After Oxford Outcomes was acquired by ICON Plc. she honed her expertise in real world evidence (RWE), spending a lot of her time on multi-national projects including prospective studies, retrospective database and chart reviews, and eliciting patient, caregiver and provider perspectives.

Rewbix
Mar 21st, 2025
Legal Turmoil for ICON Public Limited Company (ICLR): A Deep Dive into the Financial Impact of Securities Fraud Lawsuit

ICON Public Limited Company (ICLR), a leading healthcare and pharmaceutical services provider, has been hit by a securities fraud class-action lawsuit.

Rewbix
Mar 16th, 2025
Securities Fraud Class Action Lawsuit Filed Against ICON Public Limited Company (ICLR)

The law firm Kessler Topaz Meltzer & Check, LLP announced on March 16, 2025, that it has filed a securities fraud class action lawsuit against ICON Public Limited Company (ICLR).